Hectorol Label Hectored by ISMP
This article was originally published in The Pink Sheet Daily
Executive Summary
Medical safety organization says FDA will "look into" labeling of Bone Care International's Hectorol, which includes a mu and trailing zero.
You may also be interested in...
Pre-Dialysis Kidney Disease Market Heats Up With Oral Zemplar NDA, Hectorol Launch
Bone Care International's launch of the first vitamin D compound approved for secondary hyperparathyroidism in pre-dialysis patients (Hectorol) coincides with Abbott's NDA filing for Zemplar capsules.
NDAs Should Include More Cross-Study Analysis, FDA Says In Draft Guidance
FDA is clarifying that it expects sponsors to provide analysis of efficacy data rather than simply a summary of clinical data as part of the integrated summary of effectiveness in new drug applications
New Look At Ezetimibe Fails To Confirm Vytorin Cancer Signal
Interim data from SHARP and IMPROVE-IT trials fail to show evidence of impact on cancer rates.